Investing in biotech stocks can be very risky. Positive results from a clinical trial can send a stock’s valuation through the roof, while a poor result can send it crashing in a hurry. A great …
More Karuna Therapeutics’ Crash Reminds Investors How Dangerous Biotech Stocks Can Be Videos